Home Sleep Testing in Neuromuscular Disease Patients
Kata kunci
Abstrak
tanggal
Terakhir Diverifikasi: | 07/31/2014 |
Pertama Dikirim: | 06/02/2008 |
Perkiraan Pendaftaran Telah Dikirim: | 06/10/2008 |
Pertama Diposting: | 06/11/2008 |
Pembaruan Terakhir Dikirim: | 08/11/2014 |
Pembaruan Terakhir Diposting: | 08/12/2014 |
Tanggal Mulai Studi Sebenarnya: | 06/30/2008 |
Perkiraan Tanggal Penyelesaian Utama: | 08/31/2008 |
Perkiraan Tanggal Penyelesaian Studi: | 06/30/2009 |
Kondisi atau penyakit
Intervensi / pengobatan
Other: Evaluation for Nocturnal non invasive ventilation
Tahap
Kelompok Lengan
Lengan | Intervensi / pengobatan |
---|---|
1SevereRLD,NMD Patients with FEV1<40% | |
2VerySevereRLD,NMD FEV1<30% | |
3NINV FEV1<25%,on non invasive ventilation | |
ModerateRLD,NMD Patients with FEV1 40-50% of predicted |
Kriteria kelayakan
Usia yang Layak untuk Belajar | 8 Years Untuk 8 Years |
Jenis Kelamin yang Layak untuk Belajar | All |
Metode pengambilan sampel | Non-Probability Sample |
Menerima Relawan Sehat | Iya |
Kriteria | Inclusion Criteria: - Clinical diagnosis of neuromuscular disease - Must have home caregivers Exclusion Criteria: - No home caregiver |
Hasil
Ukuran Hasil Utama
1. 1. End tidal CO2 catheter is tolerated for six hours or more [3 months]
Ukuran Hasil Sekunder
1. 1. Interpretable data are captured for oximetry, heart rate, and end-tidal CO2 [3 months]
2. 2. An interpretive report is generated that will guide the non-pulmonary physician in potential interventions [6 months]
3. 2. Patients and parents are able to apply the monitors at home and a six hour data set is collected [3 months]